Cena / účetní hodnota společnosti AMAG Pharmaceuticals
Jaká je hodnota metriky Cena / účetní hodnota společnosti AMAG Pharmaceuticals?
Hodnota metriky Cena / účetní hodnota společnosti AMAG Pharmaceuticals, Inc. je 3.03
Jaká je definice metriky Cena / účetní hodnota?
Cena / učetní hodnota (Price to book ratio) je ukazatel, který vyjadřuje poměr mezi hodnotou společnosti a book value společnosti, což je hodnota čistých aktiv.
The price to book ratio, or P/B ratio, is a financial ratio used to compare a company's current market price to its book value. It is also sometimes known as a market to book ratio or price to equity ratio. The calculation of a price to book ratio can be performed in two ways. It can be calculated as the company's market capitalization divided by the company's total book value from its balance sheet. It can also be calculated using per-share values and dividing a company's current share price by the book value per share (i.e. its book value divided by the number of outstanding shares).
The P/B ratio varies between industries. The industries that require more infrastructure capital (for each dollar of profit) will usually trade at P/B ratios much lower than, for example, consulting firms. P/B ratios are commonly used to compare banks, because most assets and liabilities of banks are constantly valued at market values. A higher P/B ratio implies that investors expect management to create more value from a given set of assets, all else equal (and/or that the market value of the firm's assets is significantly higher than their accounting value).
P/B ratios do not, however, directly provide any information on the ability of the firm to generate profits or cash for shareholders. This ratio also gives some idea of whether an investor is paying too much for what would be left if the company went bankrupt immediately. For companies in distress, the book value is usually calculated without the intangible assets that would have no resale value. In such cases, P/B should also be calculated on a "diluted" basis, because stock options may well vest on sale of the company or change of control or firing of management.
Cena / účetní hodnota společností v sektoru Health Care sektor na NASDAQ ve srovnání se společností AMAG Pharmaceuticals
Čemu se věnuje společnost AMAG Pharmaceuticals?
AMAG Pharmaceuticals, Inc. is a biopharmaceutical company. It focuses on the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. The firm focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. Its products include Intrarosa, Vyleesi, Makena, CBR, Feraheme, and MuGard. The company was founded on November 9, 1981 and is headquartered in Waltham, MA.
Firmy s metrikou cena / účetní hodnota podobnou společnosti AMAG Pharmaceuticals
- Hodnota metriky Cena / účetní hodnota společnosti Federated Hermes Inc je 3.03
- Hodnota metriky Cena / účetní hodnota společnosti Charles River Laboratories International je 3.03
- Hodnota metriky Cena / účetní hodnota společnosti Envela Corp je 3.03
- Hodnota metriky Cena / účetní hodnota společnosti Audiocodes je 3.03
- Hodnota metriky Cena / účetní hodnota společnosti Bluegreen Vacations je 3.03
- Hodnota metriky Cena / účetní hodnota společnosti Hunters Property Plc je 3.03
- Hodnota metriky Cena / účetní hodnota společnosti AMAG Pharmaceuticals je 3.03
- Hodnota metriky Cena / účetní hodnota společnosti Numinus Wellness Inc je 3.04
- Hodnota metriky Cena / účetní hodnota společnosti Travel Technology Interactive je 3.04
- Hodnota metriky Cena / účetní hodnota společnosti Tortoise Midstream Fund Inc je 3.04
- Hodnota metriky Cena / účetní hodnota společnosti Bourse Direct SA je 3.04
- Hodnota metriky Cena / účetní hodnota společnosti Wolverine World Wide je 3.04
- Hodnota metriky Cena / účetní hodnota společnosti West African Resources je 3.04